Trial ID 20189 | Maryland Oncology Hematology Trial ID 20189 – Maryland Oncology Hematology

Trial ID 20189

Trial Information - Phase III

A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy

Protocol ID: INCMGA 0012-303

Sponsor: Incyte Corporation

Status: OPEN TO ENROLLMENT

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Anal

Investigator

Gaffar MD, Yousuf

Status

OPEN TO ENROLLMENT

Sponsor

Incyte Corporation

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology